Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bishop

Showing results (821-830 of 1,042) with videos related to

Pageof 105
Sort By:
Journal of Geriatric Oncology|November 9, 2020
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patientsBenjamin A Derman, Keriann Kordas, Emily Molloy, et al.
Schizophrenia Research|August 25, 2020
Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relativesWilliam C Hochberger, Courtney L M Eskridge, Jeffrey R Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignanciesRachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Schizophrenia Research|October 24, 2017
Genetic analysis of deep phenotyping projects in common disordersElliot S Gershon, Godfrey Pearlson, Matcheri S Keshavan, et al.
Blood Advances|July 19, 2022
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCTMisha C Tran, Yasmin Hasan, Amy Wang, et al.
Nature Structural & Molecular Biology|July 24, 2023
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilitiesYuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 PandemicVeronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 8, 2019
Brain gray matter network organization in psychotic disordersWenjing Zhang, Du Lei, Sarah K Keedy, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Pageof 105

Showing results (821-830 of 1,042) with videos related to

Sort By:
Pageof 105
Journal of Geriatric Oncology|November 9, 2020
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patientsBenjamin A Derman, Keriann Kordas, Emily Molloy, et al.
Schizophrenia Research|August 25, 2020
Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relativesWilliam C Hochberger, Courtney L M Eskridge, Jeffrey R Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignanciesRachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Schizophrenia Research|October 24, 2017
Genetic analysis of deep phenotyping projects in common disordersElliot S Gershon, Godfrey Pearlson, Matcheri S Keshavan, et al.
Blood Advances|July 19, 2022
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCTMisha C Tran, Yasmin Hasan, Amy Wang, et al.
Nature Structural & Molecular Biology|July 24, 2023
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilitiesYuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 PandemicVeronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 8, 2019
Brain gray matter network organization in psychotic disordersWenjing Zhang, Du Lei, Sarah K Keedy, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Pageof 105